Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mycobacterium tuberculosis Infection remains a major global health problem complicated by escalating rates of antibiotic resistance. Despite the established role of mycolic acid cyclopropane modification in pathogenesis, the feasibility of targeting this enzyme family for antibiotic development is unknown. We show through genetics and chemical biology that mycolic acid methyltransferases are essential for M. tuberculosis viability, cell wall structure, and intrinsic resistance to antibiotics. The tool compound dioctylamine, which we show acts as a substrate mimic, directly inhibits the function of multiple mycolic acid methyltransferases, resulting in loss of cyclopropanation, cell death, loss of acid fastness, and synergistic killing with Isoniazid and Ciprofloxacin. These results demonstrate that mycolic acid methyltransferases are a promising antibiotic target and that a family of virulence factors can be chemically inhibited, with effects not anticipated from studies of each individual enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“The prevailing model of rational antimicrobial development envisions a one-to-one relationship between target and inhibitor (Mdluli and Spigelman, 2006; Payne et al., 2007).”
BackgroundOxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice
Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M., Yu, K., Quémard, A., Smith, I., & Daffé, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01882.x · Cited by 335
Rao, V., Fujiwara, N., Porcelli, S. A., & Glickman, M. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041668 · Cited by 238
Self-citationRao, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27335 · Cited by 200 · cited 6×
“tuberculosis produces a hypervirulent strain (Rao et al., 2006), we attempted to delete this gene from BCG Pasteur (BCG-P) to study its effect on BCG immunogenicity.”
Background
Cited by
Bordbar, A., Lewis, N. E., Schellenberger, J., Palsson, B. Ø., & Jamshidi, N. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.68 · Cited by 252
Tran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125
Phosphorylation of Mycobacterial PcaA Inhibits Mycolic Acid Cyclopropanation
Corrales, R. M., Molle, V., Leiba, J., Mourey, L., de Chastellier, C., & Kremer, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373209 · Cited by 70
“Enzymatic Assays—Methyltransferase activity of PcaA and MmaA2 was measured by using the couple assay for mycolic acids as described (23) with slight modifications.”
BackgroundMethodInfluentialTwo Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
Fay, A., Czudnochowski, N., Rock, J. M., Johnson, J. R., Krogan, N. J., Rosenberg, O., & Glickman, M. S. (2019) · mBio · doi:10.1128/mbio.00850-19 · Cited by 65
“tuberculosis these modifications alter 77 host-mycolic acid responses [8-14].”
BackgroundSelf-citation
Metadata
- Authors
- Barkan, D., Liu, Z., Sacchettini, J. C., & Glickman, M. S.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 16
- Issue
- 5
- Pages
- 499-509
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1991855175
- Cited by
- 125
- References
- 4
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis. https://app.cochat.ai/papers/10.1016/j.chembiol.2009.04.001
- The paper
- Barkan, D., Liu, Z., Sacchettini, J. C., & Glickman, M. S. (2009). Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis. Chemistry & Biology. https://doi.org/10.1016/j.chembiol.2009.04.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.